From TA point of view, it is on a nice uptrend mode chart patterns.
The current price of $1.25 is staying well above its 20,50,100 & 200 days moving average, this is rather bullish.
Short term wise, looks like it may likely re-attempt the recent high of $1.29.Crossing over with ease + good volume that may propel to drive the price higher towards 1.35 then 1.40 with extension to 1.46.
I think it might be good to lock in some profit !
Not a call to buy or sell.
Please do your own due diligence.
NAV of RMB5.82
EPS RMB0.62
Dividend of 2.1 us cents.
Yield of about 2.24%
Looking through their past financial nos from 2014 to 2018, we can notice that the Total Revenue is generally declining from S$1513m to S$1222m.
Net Income has been rising from S$76m to S$108m.
Even tough the Total Revenue is lower but Net Income has been rising could be due to lower costs and other gains that contributed to the rise of net income. You may want to look further into their financial report.
Diluted EPS has also been rising from 6.8 cents to 9.8 cents.
Total current assets of $904m is more than sufficient to cover its total liabilities of $447m.
Cash flow from Operations is a little bit erratic. It fluctuates up and down. So is not very consistence.
The latest 1Q 2018 result shows Net profit rises 31% from RMB133m to RMB171m.
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicines, western medicines, and healthcare products primarily in the People’s Republic of China. The company is also involved in the manufacture and sale of biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services. The company sells medicinal products under its own brand and other brands to wholesalers. Tianjin Zhong Xin Pharmaceutical Group Corporation Limited was founded in 1992 and is headquartered in Tianjin, the People’s Republic of China.
No comments:
Post a Comment